Gestational Hypertension
Conditions
Keywords
Pregnancy, hypertension, nitrate, beetroot juice
Brief summary
High blood pressure in pregnancy is associated with poor outcomes for both mum and baby, increasing the risk of pregnancy complications including pre-eclampsia, fetal growth restriction and preterm birth. The development of new blood pressure lowering interventions suitable for use in pregnancy is a key research priority. Inorganic nitrate is a compound found in certain types of food, particularly green leafy vegetables and beetroot. Nitrate provides an important source of nitric oxide (NO), a molecule involved in keeping blood vessels healthy and regulating blood pressure. Supplementation with nitrate in the diet, using interventions such as beetroot juice, has been shown to reduce blood pressure and improve blood vessel function. In order for dietary nitrate to have these beneficial effects, it needs to be converted in the body to nitrite, via bacteria that live in the mouth (oral bacteria). Differences in oral bacteria, and how they metabolise nitrate, are thought to influence blood pressure regulation and potentially response to dietary nitrate supplementation. This study aims to understand (1) whether pregnant women with high blood pressure have a different composition of oral bacteria compared to healthy pregnant women and women who are not pregnant, and (2) how differences in oral bacteria affect blood pressure responses to a dose of dietary nitrate (in the form of beetroot juice).
Interventions
DIETARY_SUPPLEMENTBeetroot juice
Beetroot juice shot (70mL containing 400mg inorganic nitrate)
Sponsors
University of Manchester
Study design
Allocation
NON_RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
BASIC_SCIENCE
Masking
NONE
Intervention model description
Beetroot juice intervention given to all participants (1 dose only)
Eligibility
Sex/Gender
FEMALE
Age
16 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
* Normotensive or hypertensive women (hypertension as systolic blood pressure \>140 mmHg and/or diastolic blood pressure \>90 mmHg OR on anti-hypertensive medication) * For pregnant women, between 20-28 weeks gestation
Exclusion criteria
* Multi-fetal pregnancy (for pregnant women) * Age under 16, or over 45 years of age * Lacking ability to consent * Pre-existing diabetes (Type 1/Type 2) * Previous history of pre-term FGR (delivery before 32 weeks with FGR) * Current tobacco smoker * Body Mass Index greater than or equal to 40 or less than or equal to 18 * Use of any of the following drugs in the last 6 months: systemic antibiotics, antifungals, antivirals or antiparasitics (intravenous, intramuscular, or oral) * Large doses of commercial probiotics (greater than or equal to 108 cfu or organisms per day) including tablets, capsules, lozenges, chewing gum or powders (ordinary dietary components such as yoghurts do not apply) * Evidence of oral disease, assessed on screening proforma (current conditions of: oral candidiasis (thrush); Dental caries (tooth decay); Halitosis; Oral ulcerations/mouth ulcers; Wisdom tooth pain; Chronic dry mouth) * Allergy to beetroot juice or lemon juice (both contained within the juice shot)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Quantity of oral nitrate reducing bacterial species | Baseline | Assessment of oral bacterial profile using next-generation sequencing (bacterial 16S rRNA sequencing) |
| Oral bacterial nitrate reductase activity | Baseline | Assessment of oral nitrate reductase activity, measured using enzyme assay |
| Difference between groups in nitrate/nitrite concentrations before and after dietary nitrate dose | Baseline to 2.5 hour post-nitrate dose | Measurement of plasma and salivary nitrate and nitrite concentrations, using high-performance liquid chromatography (HPLC) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Difference between groups in blood pressure response to dietary nitrate dose | Baseline to 2.5 hour post-nitrate dose | Change in blood pressure |
Other
| Measure | Time frame | Description |
|---|---|---|
| Correlation between salivary nitrate reductase activities and the change in salivary/plasma nitrite concentrations post-nitrate dose | Baseline to 2.5 hour post-nitrate dose | Change in nitrite vs. baseline nitrate reductase activity |
| Correlation between changes in plasma nitrite concentrations and blood pressure lowering post-nitrate dose | Baseline to 2.5 hour post-nitrate dose | Change in plasma nitrite vs. change in blood pressure |
Countries
United Kingdom
Outcome results
None listed